IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells

[1]  D. Scott‐Algara,et al.  Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT-CRP Induces Selective ROS-Dependent Apoptosis in T-Acute Lymphoblastic Leukemia Cell Lines , 2020, Journal of oncology.

[2]  M. Franco-Molina,et al.  IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  M. Amonkar,et al.  Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review , 2020 .

[4]  C. Rodríguez-Padilla,et al.  Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines , 2019, PeerJ.

[5]  P. Karoyan,et al.  PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice with Tumoral T Lymphoblasts , 2019, Journal of oncology.

[6]  E. Scarpi,et al.  Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? , 2019, Journal of oncology.

[7]  J. Woo,et al.  Resveratrol induces cell death through ROS‑dependent downregulation of Notch1/PTEN/Akt signaling in ovarian cancer cells. , 2019, Molecular medicine reports.

[8]  Xin Zhang,et al.  ROS Reduction Does Not Decrease the Anticancer Efficacy of X-Ray in Two Breast Cancer Cell Lines , 2019, Oxidative medicine and cellular longevity.

[9]  Q. Pang,et al.  ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway , 2019, OncoTargets and therapy.

[10]  B. Rapoport,et al.  Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy , 2019, International journal of molecular sciences.

[11]  P. Karoyan,et al.  CD47 agonist peptide PKHB1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells , 2018, Cancer science.

[12]  Shih-Hsiung Wu,et al.  Ergosterol peroxide from marine fungus Phoma sp. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells , 2018, Scientific Reports.

[13]  E. Baehrecke,et al.  Life, death and autophagy , 2018, Nature Cell Biology.

[14]  C. Rodríguez-Padilla,et al.  Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production , 2018, International journal of nanomedicine.

[15]  Liping Jiang,et al.  Patulin induced ROS-dependent autophagic cell death in Human Hepatoma G2 cells. , 2018, Chemico-biological interactions.

[16]  Yanying Yang,et al.  Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells , 2018, OncoTargets and therapy.

[17]  Xiu-ying Li The inducers of immunogenic cell death for tumor immunotherapy , 2018, Tumori.

[18]  C. K. Das,et al.  Pro-survival autophagy and cancer cell resistance to therapy , 2018, Cancer and Metastasis Reviews.

[19]  D. G. Lee,et al.  Reactive oxygen species-independent apoptotic pathway by gold nanoparticles in Candida albicans. , 2018, Microbiological research.

[20]  Y. Chiew,et al.  Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer , 2018, Scientific Reports.

[21]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[22]  A. C. Cruz,et al.  In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus , 2018, Scientific Reports.

[23]  M. Franco-Molina,et al.  IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production , 2018, BMC Cancer.

[24]  A. Oberst,et al.  Mitochondrial permeabilisation engages NF-κB dependent anti-tumour activity under caspase deficiency , 2017, Nature Cell Biology.

[25]  M. Franco-Molina,et al.  The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth , 2017, Oncology letters.

[26]  S. Ou,et al.  Green tea polyphenols induce cell death in breast cancer MCF-7 cells through induction of cell cycle arrest and mitochondrial-mediated apoptosis , 2017, Journal of Zhejiang University-SCIENCE B.

[27]  P. Ismail,et al.  In vitro Antiproliferative and Apoptosis Inducing Effect of Allium atroviolaceum Bulb Extract on Breast, Cervical, and Liver Cancer Cells , 2017, Front. Pharmacol..

[28]  Xiaobo B Han,et al.  ROS-Dependent Activation of Autophagy through the PI3K/Akt/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages , 2017, Oxidative medicine and cellular longevity.

[29]  A. Ouchida,et al.  The role of mitochondria in metabolism and cell death. , 2017, Biochemical and biophysical research communications.

[30]  P. Cullen,et al.  Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide , 2016, British Journal of Cancer.

[31]  Michael R Hamblin,et al.  Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death , 2015, Front. Immunol..

[32]  L. Galluzzi,et al.  eIF2α phosphorylation as a biomarker of immunogenic cell death. , 2015, Seminars in cancer biology.

[33]  Liping Jiang,et al.  Citreoviridin induces ROS-dependent autophagic cell death in human liver HepG2 cells. , 2015, Toxicon : official journal of the International Society on Toxinology.

[34]  J. Guan,et al.  Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis , 2015, Breast Cancer Research and Treatment.

[35]  P. Vandenabeele,et al.  Consensus guidelines for the detection of immunogenic cell death , 2014, Oncoimmunology.

[36]  S. Y. Kim,et al.  Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation. , 2014, Anticancer research.

[37]  M. Lotze,et al.  Strange attractors: DAMPs and autophagy link tumor cell death and immunity , 2013, Cell Death and Disease.

[38]  D. de Ruysscher,et al.  Inducers of immunogenic cancer cell death. , 2013, Cytokine & growth factor reviews.

[39]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[40]  M. Lotze,et al.  DAMPs and autophagy , 2013, Autophagy.

[41]  Abhishek D. Garg,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[42]  F. Di Virgilio,et al.  Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.

[43]  Hong Zheng,et al.  Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development , 2011, Autophagy.

[44]  M. Franco-Molina,et al.  Antiangiogenic and antitumor effects of IMMUNEPOTENT CRP in murine melanoma , 2010, Immunopharmacology and immunotoxicology.

[45]  J. Menéndez,et al.  Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab , 2009, PloS one.

[46]  S. Gorski,et al.  Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization , 2008, Breast Cancer Research and Treatment.

[47]  J. Lemasters Molecular mechanisms of cell death , 2020, Essential Concepts in Molecular Pathology.

[48]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[49]  M. Franco-Molina,et al.  Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells. , 2008, Cytotherapy.

[50]  M. Franco-Molina,et al.  In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells. , 2006, Cytotherapy.

[51]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..